Median levels of eotaxin‐3 were only assessed in CRSwNP and asthma patients, with numerically higher baseline concentrations observed in CRSwNP (60.50–61.55 and 37.45–38.30 pg/mL, respectively). Here, CCL26 is linked to asthma.